Michael Wiederhorn Analyst Performance

Managing Director at Oppenheimer

Michael Wiederhorn is a stock analyst at Oppenheimer focused in the medical sector, covering 20 publicly traded companies. Over the past year, Michael Wiederhorn has issued 9 stock ratings, including and buy recommendations. While full access to Michael Wiederhorn's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Wiederhorn's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

106 Last 11 Years

Buy Recommendations

94.06% 95 Buy Ratings

Companies Covered

20 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	94.1%	95 ratings
Hold	5.9%	6 ratings
Sell	0.0%	0 ratings

Out of 101 total stock ratings issued by Michael Wiederhorn at Oppenheimer, the majority (94.1%) have been Buy recommendations, followed by 5.9% Hold.

Best & Worst Calls

• Best Call

  0000.0%

  CNC

  Feb 2020

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  CYH

  Jun 2015

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NYSE	60.0% of companies on NYSE	12 companies
NASDAQ	40.0% of companies on NASDAQ	8 companies

Michael Wiederhorn, an analyst at Oppenheimer, currently covers 20 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 18 companies	90.0%
	Miscellaneous 1 company	5.0%
	Business Services 1 company	5.0%

Michael Wiederhorn of Oppenheimer specializes in stock coverage within the Medical sector, with additional focus on and Business Services companies.

Coverage Industries

Industry	Percentage
MED - HMO 4 companies	20.0%
MED - OUTP/HM CRE 3 companies	15.0%
MEDICAL SERVICES 3 companies	15.0%
MED - HOSPITALS 2 companies	10.0%
HEALTH INFORMATION SERVICES 1 company	5.0%
MISCELLANEOUS HEALTH & ALLIED SERVICES 1 company	5.0%
MED - NURSING HMS 1 company	5.0%
HOME HEALTH CARE SERVICES 1 company	5.0%
Miscellaneous 1 company	5.0%
OFFICES & CLINICS OF MEDICAL DOCTORS 1 company	5.0%
STAFFING 1 company	5.0%
HOSPITAL & MEDICAL SERVICE PLANS 1 company	5.0%

About Michael Wiederhorn

Michael Wiederhorn is Managing Director and Senior Analyst covering Healthcare Providers and Services. His coverage focuses on managed care, hospitals, nursing homes, home health, hospice, emergency services, and related healthcare services. He has over fifteen years of experience in healthcare consulting and research and in 2013, he was honored as a top ranked Earnings Estimator in Health Care Providers & Services 2013 by Financial Times/Starmine. In addition, in 2009 and 2010, Michael was ranked the #1 brokerage analyst for Medical Care by Forbes Magazine. Prior to entering equity research, Michael was a management consultant at Ernst and Young, serving the healthcare industry. He has a Masters in Health Policy and Management from Harvard University and BA in American History from the University of Pennsylvania.

Follow on LinkedIn

Michael Wiederhorn's Ratings History at Oppenheimer

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
CHE Chemed	7/31/2025	Lower Price Target	$416.31	$580.00	Outperform	$0.00 00.00% ROI
UNH UnitedHealth Group	7/30/2025	Lower Price Target	$260.85	$325.00	Outperform	$0.00 00.00% ROI
CNC Centene	7/28/2025	Lower Price Target	$27.70	$43.00	Outperform	$0.00 00.00% ROI
CNC Centene	7/15/2025	Lower Price Target	$30.37	$51.00	Outperform	$0.00 00.00% ROI
UNH UnitedHealth Group	5/14/2025	Lower Price Target	$314.38	$400.00	Outperform	$0.00 00.00% ROI
HUM Humana	5/1/2025	Boost Price Target	$259.54	$310.00	Outperform	$0.00 00.00% ROI
UNH UnitedHealth Group	4/21/2025	Lower Price Target	$456.10	$600.00	Outperform	$0.00 00.00% ROI
CI Cigna Group	1/31/2025	Lower Price Target	$296.88	$375.00	Outperform	$0.00 00.00% ROI
TDOC Teladoc Health	1/24/2025	Lower Price Target	$10.22	$12.00	Outperform	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.